Background Bacterial vaginosis (BV) is a vaginal disorder characterized by a depletion of the normal lactobacillus-dominant microbiota and overgrowth of mainly anaerobic bacteria. Objectives The study aimed to evaluate the distribution and abundance of the Gardnerella vaginalis clades and sialidase A gene in vaginal samples from Russian women, and investigate if the G. vaginalis sialidase A gene count detects an abnormal vaginal microbiota characteristic of BV more accurately than G. vaginalis load. Methods Vaginal samples from 299 non-pregnant patients of gynecological clinics were examined using Nugent scores and G. vaginalis clade and sialidase A gene quantitative real-time polymerase chain reactions (PCRs). Discriminatory power for BV microbiota was evaluated with receiver operating characteristic (ROC) analysis. Results The vaginal microbiota was characterized by Nugent scores as normal, intermediate, and BV microbiota in 162, 58, and 79 women, respectively. G. vaginalis clades 1, 2, 3, 4, and the sialidase A gene were detected in 56% (51-62%), 40% (34-45%), 20% (16-25%), 94% (91-96%), and 70% (64-75%) of vaginal samples, respectively. The frequency and abundance of clades 1, 2, 4, and the sialidase A gene as well as clade multiplicity were significantly associated with abnormal microbiota. The sialidase A gene was present in all multi-clade samples, in all single-clade samples comprising clades 1, 2, and 3, and in four of 84 (5% [2-12%]) samples comprising clade 4 only. Total G. vaginalis load showed significantly higher discriminatory power for abnormal microbiota than sialidase A gene count (areas under ROC curves 0.933 vs. 0.881; p = 0.0306). Conclusions Quantifying all four G. vaginalis clades discriminates between BV microbiota and normal microbiota more accurately than measuring G. vaginalis sialidase A gene. Clade 4 is strongly associated with BV microbiota, despite most clade 4 strains lacking the sialidase A gene.
Introduction
Bacterial vaginosis (BV) is a vaginal disorder characterized by a depletion of the normal lactobacillus-dominant microbiota and overgrowth of mainly anaerobic bacteria, i.e., an abnormal vaginal microbiota. Clinically, BV is manifested as abnormal malodorous vaginal discharge, but an abnormal vaginal microbiota characteristic of BV can be detected also in asymptomatic individuals [1] . BV is associated with an increased risk of many gynecological and obstetrical complications [2] [3] [4] [5] . Gardnerella vaginalis is a common bacterial species in the vaginal microbiota and can be found in many healthy women. However, it is substantially more abundant and nearly ubiquitous in women with BV [6, 7] . G. vaginalis is considered to play a key role in the pathogenesis of BV, being an initial colonizer of the vaginal epithelium due to the higher adhesion, cytotoxicity, and greater propensity to form biofilm (compared to other BV-associated bacteria), and acting as a scaffold to which other species subsequently can attach [8] [9] [10] .
Gardnerella vaginalis is a phenotypically and genetically heterogeneous species [11] [12] [13] [14] [15] [16] [17] . Eight metabolic biotypes of G. vaginalis were identified early based on the presence of β-galactosidase, lipase, and hippurate hydrolysis activities [11] , and 17 biotypes based on these characteristics and additionally on utilization of xylose, arabinose, and galactose [12] . Phenotypic diversity within the G. vaginalis species has also been shown in relation to virulence factors, such as production of sialidase and vaginolysin, initial adhesion, cytotoxic effect, biofilm formation, susceptibility to antimicrobials, and the ability of G. vaginalis to displace lactobacilli adhered to HeLa cells [18] [19] [20] [21] [22] . Association of G. vaginalis biotypes with BV has been evaluated in a number of studies, but the results have been contradictory [11, 19, 20, [23] [24] [25] . Sialidase is utilized by some BV-associated bacteria, including G. vaginalis, for degradation and depletion of protective host mucus barriers [26, 27] . Detection of the BV virulence factor sialidase has also been used in rapid point-of-care tests for BV, e.g., BVBlue ® (Sekisui Diagnostics, L.L.C., Birmingham, AL, USA) [28] .
Genetic heterogeneity within the G. vaginalis species has been demonstrated using molecular approaches, such as amplified ribosomal DNA restriction analysis (ARDRA) [13] . Using this method, three distinct G. vaginalis genotypes were identified, of which two produced sialidase. Although a link with sialidase production was shown for particular G. vaginalis ARDRA genotypes [18, 20] , no clear association between BV and any of the ARDRA genotypes has been identified [18] . Different genetic variants of G. vaginalis based on a comparative genomic analysis have been described, and evidence of substantial differences in metabolic and virulence potential between G. vaginalis clinical strains has been reported [14, 15] .
More recently, detailed genomic analyses [16] have identified four main clades within the G. vaginalis species. There were substantial differences in genome size, GC ratio, and core gene content between the clades, suggesting a possibility of considering them as separate bacterial species. Four subgroups of G. vaginalis (subgroups A-D), based on sequencing of a region of the chaperonin-60 (cpn60) gene, have also been proposed to represent different species [17] . Subsequently, G. vaginalis clades 1-4 were reconciled with cpn60 subgroups A-D [29] : cpn60 subgroup A corresponded to clade 4, subgroup B to clade 2, subgroup C to clade 1, and subgroup D to clade 3. In the same study [29] , presence and activity of the putative sialidase A gene were investigated in G. vaginalis isolates. All isolates of subgroups B, C, and D, but only one (3%) of the subgroup A isolates, possessed the putative sialidase A gene, while sialidase activity was displayed by all isolates of subgroup B, three (9%) subgroup C isolates, and none of the isolates of subgroups A and D, suggesting that this gene is not expressed (or not constitutively expressed) in many isolates. An association of the G. vaginalis sialidase A gene, as a proxy for sialidase production, with biofilm on the vaginal epithelium and with BV was subsequently examined [30] . The sialidase A gene was detected in 75% of G. vaginalispositive vaginal samples, and there was a strong association between high counts of the G. vaginalis sialidase A gene, the presence of G. vaginalis biofilm, and BV [30] . These observations indicate distinct clinical and diagnostic relevance of G. vaginalis subgroups/clades for BV.
The objectives of this study were to evaluate the distribution and abundance of the G. vaginalis clades, corresponding to the cpn60 subgroups, and putative sialidase A gene in vaginal samples from Russian women with normal and BV microbiota, and to investigate if G. vaginalis sialidase A gene counts can detect an abnormal microbiota characteristic of BV more accurately than G. vaginalis bacterial load.
Materials and Methods

Patients, Specimens and Bacterial Vaginosis Diagnosis
The study subjects were women of reproductive age (from 18 to 54 years) who attended gynecological clinics in St Petersburg, Russia with vaginal symptoms (mainly abnormal vaginal discharge) from October to December 2015. The exclusion criteria were pregnancy and taking oral or intravaginal antimicrobials within the last month. 
Quantitative Polymerase Chain Reaction (PCR) Detection of the Gardnerella vaginalis Clades and the Putative G. vaginalis Sialidase A Gene
The detection of the four clades of G. vaginalis [16] was performed using a multiplex real-time PCR assay with previously described primers and probes [32] . Real-time PCR analysis of the G. vaginalis sialidase A gene was performed using the forward primer GVSI forward (5′-GAC GAC GGC GAA TGG CAC GA-3′), designed by Santiago et al. [18] , and the newly designed reverse primer GvSia1R2 (5′-GCT GTA TCC GTC TAC GTA AATG-3′) and TaqMan ® probe GvSia1Z2r (5′-R6G-CTC CGC GAT TTG CGC GAA TAATC-BHQ1-3′ [18] , and corresponding sequences of other G. vaginalis strains (belonging to different clades), described in the study by Ahmed et al. [16] . In this sequence alignment, the previously used reverse primer GVSI [18] had two mismatches at the 3ʹ-end in some strains, which could reduce the sensitivity of detecting some G. vaginalis strains. A new TaqMan ® hybridization probe specific for the conservative part of the chosen fragment was also designed to enable accurate, sensitive, and specific detection. Specificity of the newly designed primer and probe was verified using Standard Nucleotide BLAST ® (Basic Local Alignment Search Tool) software (NCBI; https ://blast .ncbi.nlm.nih.gov/Blast .cgi).
DNA for both PCR assays was isolated from 100 μL of sample using the silica-based manual extraction kit DNASorb-AM (InterLabService, Moscow, Russia), according to the manufacturer's instructions, with an elution volume of 100 μL. The DNA preparations were stored at 4 °C prior to amplification, which was performed within 3 days.
PCR amplifications were performed in reactions (25 µL) containing 10 µL of Mix-1 (0.7 pmol/µL of each primer, 0.2 pmol/µL of each probe, 0.44 mM deoxyribonucleotide triphosphates (dNTPs), 0.1 mM Tris, and 0.1 mM EDTA), 5 µL of Mix-2 (20% glycerol, 0.17 M Tris-HCl (pH 8.3), 42 mM (NH 4 ) 2 SO 4 , 0.025% Tween-20, 7.5 mM MgSO 4 , 0.25 mg/mL of bovine serum albumin (BSA), 0.02% xylenethanol, 0.125% sodium azide, 0.5 U/µL of Taq-polymerase), and 10 µL of DNA template. The PCR program parameters were as follows: 95 °C for 15 min followed by 40 cycles of 95 °C for 15 s, 60 °C for 20 s, and 72 °C for 15 s, with fluorescence read at 60 °C. All PCR amplifications were performed on a Rotor-Gene Q instrument (QIAGEN, Hilden, Germany). Negative controls (sterile nucleic acidfree water) were included in each run.
For quantification of PCR-amplified fragments, quantitative standard samples were constructed by cloning PCR fragments of the targeted genes into pGEM ® -T Vector Systems (Promega, Madison, USA). DNA concentration of plasmid preparations was tested using digital PCR with the same specific primers and probes on a QX100™ Droplet Digital™ PCR System (BioRad, Hercules, CA, USA). Standard curves were generated by testing quantitative standard samples (in duplicate) in concentrations of 10 , and 10 9 genome equivalents (geqs)/mL for all targets. Concentrations in the clinical samples were expressed as geqs/mL of DNA extract.
Statistical Analyses
Based on the Nugent scores, all women were divided into three groups, i.e., women with normal vaginal microbiota (a score of 0-3), intermediate microbiota (4) (5) (6) , and BV microbiota (7-10) [31] . Categorical variables (the presence of the G. vaginalis clades and sialidase A gene and the presence of multiple G. vaginalis clades) were evaluated using Pearson's Chi squared test for all three groups of patients, with Cramer's V coefficient measured to evaluate the strength of association, which was followed by pairwise comparisons using Fisher's exact test. Continuous data (the loads of the G. vaginalis clades and sialidase A gene), after being characterized as not normally distributed in the Shapiro-Wilk test, were analyzed using the Kruskal-Wallis test for all three groups followed by post hoc pairwise comparisons using Dunn's multiple comparisons test. All percentages were reported with 95% confidence intervals (CIs), computed with the use of Wilson's method with Brown's modification. To assess the ability to differentiate between samples with normal and abnormal vaginal microbiota using total G. vaginalis DNA load, G. vaginalis clades and sialidase A gene counts, receiver operating characteristic (ROC) curves were plotted, and classification performance characteristics (areas under the curves [AUCs], as well as true positive proportion [sensitivity], true negative proportion [specificity], and Youden's index in optimum points) were computed. Differences between AUC values were assessed using the DeLong method. Statistical analyses were performed with the use of the statistical packages GraphPad Prism version 7.04 for Windows (GraphPad Software, San Diego, CA, USA) and Analyse-It for Microsoft Excel 5.11 (Analyse-it Software, Leeds, UK). All tests for significance were twosided, and statistically significant differences were assumed when p < 0.05.
Results
In total, 299 women aged 18-54 years (median age 30 years; mean age 32 years) were enrolled in the study. (Fig. 1) .
The With the use of ROC analysis, we evaluated the usefulness of DNA counts of the G. vaginalis clades and putative sialidase A gene for distinguishing BV microbiota from normal microbiota (Fig. 2) . Total G. vaginalis load possessed a superior discriminatory power (AUC 0. 0.767). The clade 3 count, as expected, showed no discriminatory ability for BV microbiota (AUC 0.517). The AUC for sialidase A gene count significantly exceeded those for clade 1 and 2, showed no difference with that for clade 4, and was significantly lower than that for total G. vaginalis load (Table 3) .
Discussion
Since the four clades of G. vaginalis were described, several studies have investigated their association with BV. Balashov et al. [32] developed a real-time PCR assay for detection of the four clades in clinical vaginal samples and found positive correlations between BV and clades 1 and 3, but not clades 2 and 4. The presence of multiple clades, which was detected in 70% of samples, was associated with BV. More recently, it was shown that clades 1 and 2 were significantly more common in BV samples (Nugent score 7-10), whereas clades 3 and 4 had no association with BV, and multi-clade G. vaginalis communities were associated with Nugent score ≥ 4 [33] . In a recent cohort study [34] , it was demonstrated that young women who developed BV were more likely to have clade 4 than those reporting no sex or who practiced noncoital activities. Furthermore, vaginal samples were more likely to contain multiple G. vaginalis clades rather than a single clade if women engaged in penile-vaginal sex or were diagnosed with BV. Hilbert et al. [35] , studying G. vaginalis population dynamics in BV, revealed a predominance In a previous study by our group [36] , which evaluated a PCR test for diagnosis of BV, significant difference between BV and normal vaginal samples was observed for G. vaginalis clades 1/2 (the PCR assay did not differentiate between clades 1 and 2), 3, and 4 in both detection rates and concentrations, and the presence of multiple clades was strongly associated with higher G. vaginalis loads. In our present study, for detection of the G. vaginalis clades we used the PCR assay developed by Balashov et al. [32] , for comparability with the previous studies by other groups [32] [33] [34] [35] .
The most common G. vaginalis clade among the Russian women examined in our study was clade 4 (94%), followed by clade 1 (56%), clade 2 (40%), and clade 3 (20%). In concordance with previous studies, although the prevalence figures slightly differed, clades 4 and 1 were the most prevalent [32, 33, 35] . In the present study, G. vaginalis clades 1, 2, and 4 were detected significantly more often and in significantly higher loads in women with BV microbiota than in those with normal vaginal microbiota. Clade 3 showed no association with abnormal microbiota.
Our results confirm that clade multiplicity is strongly associated with abnormal microbiota characteristic of BV. The presence of multiple clades in the vagina might be associated with having multiple sexual partners and engaging in unprotected penile-vaginal sex, which has also been previously suggested [32, 33, 35] . It should also be noted that the G. vaginalis clade multiplicity is consistent with the overall increased microbial diversity associated with abnormal vaginal microbiota. Another reason can be the biofilm character of BV. It is well-recognized that bacteria in BV are frequently present in biofilms, including densely populated microbial communities, which at least partly explains the significantly higher loads of BV-associated bacteria in the vagina of women with BV than in healthy women. BV biofilm might incorporate different bacteria, including different G. vaginalis strains, over time, so it can be hypothesized that biofilm forms of G. vaginalis in BV are commonly multi clade, whereas dispersed forms of the organism in healthy women are single clade. Furthermore, these multi-clade G. vaginalis biofilms can be transmitted between sexual partners, as shown by Swidsinski et al. [37] , who found cohesive G. vaginalis forms in all patients with proven BV and their partners using fluorescence in situ hybridization (FISH) analysis. Studies into G. vaginalis forms in normal vaginal and BV samples using clade-specific FISH analysis might help to elucidate this issue.
Sialidase production is considered an important virulence factor in BV and aerobic vaginitis [26, 38] , and is associated with adverse pregnancy outcomes [39] . Sialidase is a hydrolytic enzyme that degrades protective mucus barriers cleaving sialic acid from terminal glycans of sialoglycoproteins, which are major constituents of mucus [40] . It has been previously demonstrated that not all G. vaginalis strains, including those possessing the sialidase gene, produce sialidase [18, 20, 27, 29] . In the present study, the G. vaginalis sialidase A gene was detected in 208 (70%) women, and its distribution and abundance were strongly associated with abnormal microbiota. Due to the presence of multiple clades in the majority of samples, it was not possible to evaluate the exact frequency of the sialidase A gene in the strains of each G. vaginalis clade. Nevertheless, our results suggest that most clade 4 strains lack the sialidase A gene. Previous analysis of cultured G. vaginalis strains demonstrated the presence of the G. vaginalis sialidase A gene in all clade 1, 2, and 3 strains and in only 3% of clade 4 strains [29] . Furthermore, in the study by Janulaitiene et al. [33] , the G. vaginalis sialidase A gene was detected in all clade 1 and clade 2 isolates, but in none of the clade 4 strains. Quantification of the loads of the individual G. vaginalis clades and sialidase A gene in the vaginal samples enabled us not only to estimate a difference in those between women with normal microbiota and abnormal microbiota characteristic of BV, but also, using ROC analysis, to investigate if measuring the levels of the G. vaginalis sialidase A gene can differentiate better between normal and BV microbiota than measuring the loads of G. vaginalis clades, individually and combined. The AUC value for the sialidase A gene (0.881) significantly exceeded that for clade 1 (0.827) and 2 (0.767), but showed no main difference compared with that for clade 4 (0.857) (clade 3 showed no discriminatory capacity for abnormal microbiota). However, the superior AUC value was obtained for the total G. vaginalis load (0.933), which was significantly higher than that for the G. vaginalis sialidase A gene. Accordingly, the sialidase A gene PCR mostly detects G. vaginalis strains belonging to clades 1, 2, and 3, which are known to contain this gene. However, quantitative detection of all G. vaginalis clades, including clade 4, which appears mostly to lack the sialidase A gene, significantly increased the ability to discriminate between normal and BV microbiota. Thus, in the present study G. vaginalis clade 4 was significantly associated with abnormal vaginal microbiota characteristic of BV. This is in disagreement with the studies by Balashov et al. [32] and Janulaitiene et al. [33] , where clade 4 did not relate to BV. This discrepancy can be explained by a higher rate of detection of clade 4 in normal vaginal samples in those studies. Furthermore, in contrast to those studies, we compared not only the distribution but also the abundance of the individual G. vaginalis clades between groups of patients and demonstrated that in the vagina of women with normal microbiota clade 4 was present in significantly lower loads than in women with abnormal microbiota, which was confirmed by the results of our ROC analysis. It is noteworthy that about 10% (eight of 79) of all G. vaginalis-positive samples from women with BV microbiota in our study comprised solely clade 4, with all samples lacking the sialidase A gene. It is not clear whether G. vaginalis clade 4 strains can produce other enzymes with mucinase activity, or if other coexisting BV-associated bacteria possessing sialidase activity, e.g., Prevotella spp., Porphyromonas spp., and Bacteroides spp. [27, 41] , can degrade mucin. In the present study, the specimens were not analyzed for phenotypic sialidase activity, which limits the interpretation of our results. Harwich et al. [14] suggested that there is no direct link of sialidase production in G. vaginalis with biofilm formation or BV, because both of two investigated G. vaginalis BV isolates, one sialidase negative and one sialidase positive, had a significantly increased biofilmforming capacity, aggregation, and epithelial cell adherence compared with the non-BV sialidase-negative isolate. This suggestion was recently confirmed by Janulaitiene et al. [42] , who found significant difference between G. vaginalis clades 1, 2, and 4 in sialidase activity (clade 2 had the highest, clade 1 intermediate, and clade 4 the lowest sialidase activity) but no significant difference between the clades in biofilm-forming ability.
Another limitation of our study is that no data on clinical manifestations specific for BV were available. It should be emphasized that the Nugent scores applied in this study, as well as other laboratory methods for BV diagnosis, reveal abnormal vaginal microbiota, which can be asymptomatic or manifest as the clinical syndrome BV. It cannot be excluded that there were no main symptoms of BV in the women comprising solely sialidase-free G. vaginalis strains. Future studies are warranted to verify associations between the presence of the G. vaginalis sialidase A gene, sialidase production, biofilm forming, clinical signs of BV, and BV recurrence.
It should also be noted that we used the combined loads of the four G. vaginalis clades as a proxy for total G. vaginalis load. This assumption was based on the data of Balashov et al. [32] , who validated their clade-specific PCR using 39 cultured G. vaginalis strains and 60 vaginal samples in comparison with three G. vaginalis species-specific PCRs, which targeted the tuf gene [32] , the 16S ribosomal RNA (rRNA) gene [43] , and the cpn60 gene [44] . All G. vaginalis strains were positive by the PCRs targeting the tuf and 16S rRNA genes, and all but one of the G. vaginalis strains were successfully typed by the clade-specific PCR. The cpn60 PCR missed all strains (n = 14) typed as clades 2 or 4 by the clade-specific PCR. Of the 60 clinical vaginal samples, 59 were positive for G. vaginalis by both the tuf PCR and clade-specific PCR, 58 samples were positive by the 16S rRNA PCR, and 44 samples were positive by the cpn60 PCR. These results suggest that the clade-specific PCR detects the large majority of G. vaginalis-positive samples. Nevertheless, there are data on a limited sensitivity of this clade-specific PCR for the detection of clade 2 and 3 (cpn60 subgroup B and D, respectively) [29] . It is possible that there are molecular variants within the subgroups or additional G. vaginalis subgroups to the four that have already been described. Ideally, only thoroughly validated G. vaginalis PCRs proven to detect all G. vaginalis clades/subgroups/ variants should be used for diagnostic purposes.
Conclusions
The findings of the present study indicate that the detection of all four G. vaginalis clades discriminates between normal vaginal microbiota and abnormal vaginal microbiota characteristic of BV more accurately than measuring G. vaginalis sialidase A gene count, and there is a strong association of G. vaginalis clade 4 with BV microbiota, although most of the clade 4 strains appear to lack the sialidase A gene. Our results support previous observations that G. vaginalis clades 4 and 1 are the most prevalent in vaginal samples, and clade multiplicity is strongly associated with BV microbiota.
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